Gujarat Themis Biosyn Stock Soars to All-Time High, Signaling Market Dominance

Gujarat Themis Biosyn has reached an all-time high, with its stock price hitting Rs. 465.3 on October 23, 2025. This milestone reflects the company's strong performance in the pharmaceuticals and biotechnology sector, particularly as a small-cap player.
Despite a slight decline of 1.23% today, Gujarat Themis Biosyn has shown impressive growth over the past year, with a remarkable increase of 50.98%, significantly outperforming the Sensex, which rose by 6.32% during the same period. The stock has also demonstrated robust performance over longer time frames, with a staggering 380.47% increase over the past three years and an extraordinary 1217.60% rise over the last five years.

The stock's current trading position is above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend in its valuation. While the stock has recently experienced a trend reversal after six consecutive days of gains, its overall performance metrics highlight Gujarat Themis Biosyn's solid market position and resilience in the competitive landscape.